Mostrar el registro sencillo del ítem

Artículo

dc.creatorMellado Gil, José Manueles
dc.creatorFuente Martín, Estheres
dc.creatorLorenzo Ovejero, Petra Isabeles
dc.creatorCobo Vuilleumier, Nadiaes
dc.creatorLópez Noriega, Liviaes
dc.creatorMartín Montalvo, Alejandroes
dc.creatorGracia Herrera Gómez, Irene dees
dc.creatorCeballos Chávez, Maríaes
dc.creatorRomero Zerbo, Silvana Y.es
dc.creatorHmadcha, Abdelkrimes
dc.creatorSoria Escoms, Bernates
dc.creatorBermúdez Silva, Francisco Javieres
dc.creatorReyes, José C.es
dc.creatorGauthier, Benoit R.es
dc.date.accessioned2018-10-17T15:10:46Z
dc.date.available2018-10-17T15:10:46Z
dc.date.issued2018
dc.identifier.citationMellado Gil, J.M., Fuente Martín, E., Lorenzo Ovejero, P.I., Cobo Vuilleumier, N., López Noriega, L., Martín Montalvo, A.,...,Gauthier, B.R. (2018). The type 2 diabetes-associated HMG20A gene is mandatory for islet beta cell functional maturity article. Cell Death and Disease, 9 (3), 279.
dc.identifier.issn2041-4889es
dc.identifier.urihttps://hdl.handle.net/11441/79534
dc.description.abstractHMG20A (also known as iBRAF) is a chromatin factor involved in neuronal differentiation and maturation. Recently small nucleotide polymorphisms (SNPs) in the HMG20A gene have been linked to type 2 diabetes mellitus (T2DM) yet neither expression nor function of this T2DM candidate gene in islets is known. Herein we demonstrate that HMG20A is expressed in both human and mouse islets and that levels are decreased in islets of T2DM donors as compared to islets from non-diabetic donors. In vitro studies in mouse and human islets demonstrated that glucose transiently increased HMG20A transcript levels, a result also observed in islets of gestating mice. In contrast, HMG20A expression was not altered in islets from diet-induced obese and pre-diabetic mice. The T2DM-associated rs7119 SNP, located in the 3′ UTR of the HMG20A transcript reduced the luciferase activity of a reporter construct in the human beta 1.1E7 cell line. Depletion of Hmg20a in the rat INS-1E cell line resulted in decreased expression levels of its neuronal target gene NeuroD whereas Rest and Pax4 were increased. Chromatin immunoprecipitation confirmed the interaction of HMG20A with the Pax4 gene promoter. Expression levels of Mafa, Glucokinase, and Insulin were also inhibited. Furthermore, glucose-induced insulin secretion was blunted in HMG20A-depleted islets. In summary, our data demonstrate that HMG20A expression in islet is essential for metabolism-insulin secretion coupling via the coordinated regulation of key islet-enriched genes such as NeuroD and Mafa and that depletion induces expression of genes such as Pax4 and Rest implicated in beta cell de-differentiation. More importantly we assign to the T2DM-linked rs7119 SNP the functional consequence of reducing HMG20A expression likely translating to impaired beta cell mature function.es
dc.description.sponsorshipJunta de Andalucía PI-0727-2010, PI-0085-2013, PI-0006-2016, PI-0574-2012, P10.CTS.6359, P09-CTS-5445, RH-0070-2013, C-0070-2012es
dc.description.sponsorshipMinisterio de Economía y Competitividad PI10/00871, PI13/00593, BFU2014-5343-P, RD12/0019/0028, IJCI-2015-26238es
dc.formatapplication/pdfes
dc.language.isospaes
dc.publisherSpringer Nature [academic journals on nature.comes
dc.relation.ispartofCell Death and Disease, 9 (3), 279.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleThe type 2 diabetes-associated HMG20A gene is mandatory for islet beta cell functional maturity articlees
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.relation.projectIDPI-0727-2010es
dc.relation.projectIDPI-0085-2013es
dc.relation.projectIDPI-0006-2016es
dc.relation.projectIDPI-0574-2012es
dc.relation.projectIDP10.CTS.6359es
dc.relation.projectIDP09-CTS-5445es
dc.relation.projectIDRH-0070-2013es
dc.relation.projectIDC-0070-2012es
dc.relation.projectIDPI10/00871es
dc.relation.projectIDPI13/00593es
dc.relation.projectIDBFU2014-5343-Pes
dc.relation.projectIDRD12/0019/0028es
dc.relation.projectIDIJCI-2015-26238es
dc.relation.publisherversionhttps://doi.org/10.1038/s41419-018-0272-zes
dc.identifier.doi10.1038/s41419-018-0272-zes
idus.format.extent15 p.es
dc.journaltitleCell Death and Diseasees
dc.publication.volumen9es
dc.publication.issue3es
dc.publication.initialPage279es
dc.contributor.funderJunta de Andalucía
dc.contributor.funderMinisterio de Economía y Competitividad (MINECO). España

FicherosTamañoFormatoVerDescripción
s41419-018-0272-z.pdf2.489MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional